217 related articles for article (PubMed ID: 7188882)
21. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
Micetich K; Zwelling LA; Kohn KW
Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
[TBL] [Abstract][Full Text] [Related]
22. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
23. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
Melvik JE; Pettersen EO
Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
Swinnen LJ; Ellis NK; Erickson LC
Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II).
Zwelling LA; Kohn KW; Ross WE; Ewig RA; Anderson T
Cancer Res; 1978 Jun; 38(6):1762-8. PubMed ID: 565680
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
Murray D; Meyn RE
Cancer Res; 1986 May; 46(5):2324-9. PubMed ID: 3697977
[TBL] [Abstract][Full Text] [Related]
27. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.
Barlogie B; Corry PM; Drewinko B
Cancer Res; 1980 Apr; 40(4):1165-8. PubMed ID: 7188883
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system.
Masuda H; Tanaka T; Matsushima S
Anticancer Res; 1998; 18(3A):1473-7. PubMed ID: 9673358
[TBL] [Abstract][Full Text] [Related]
29. The effect of cis-diamminedichloroplatinum (II) on the formation of DNA-Pt-DNA cross-links.
Walter Z; Spychała M
Acta Biochim Pol; 1991; 38(1):95-9. PubMed ID: 1796714
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
31. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis.
Urano M; Kahn J; Majima H; Gerweck LE
Int J Hyperthermia; 1990; 6(3):581-90. PubMed ID: 2376671
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of DNA-reactive antineoplastic agents and protection against S-phase-specific agents by anguidine in Chinese hamster ovary cells.
Hromas R; Barlogie B; Swartzendruber D; Drewinko B
Cancer Res; 1983 Jul; 43(7):3070-3. PubMed ID: 6189590
[TBL] [Abstract][Full Text] [Related]
33. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.
Ali-Osman F; Rairkar A; Young P
Cancer Biochem Biophys; 1995 Jan; 14(4):231-41. PubMed ID: 7767897
[TBL] [Abstract][Full Text] [Related]
34. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
35. Reduction in cis-diamminedichloroplatinum(II)-induced cytotoxicity, sister chromatid exchange, and DNA interstrand cross-links in 9L cells treated with the polyamine biosynthesis inhibitor (2R,5R)-6-heptyne-2,5-diamine.
Milam KM; Hunter KJ; Deen DF; Marton LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):6945-8. PubMed ID: 2582436
[TBL] [Abstract][Full Text] [Related]
36. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
37. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
[TBL] [Abstract][Full Text] [Related]
38. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.
Ali-Osman F; Berger MS; Rairkar A; Stein DE
J Cell Biochem; 1994 Jan; 54(1):11-9. PubMed ID: 8126081
[TBL] [Abstract][Full Text] [Related]
39. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
40. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
